Sort
51,593 grants matching “hepatitis”
DEMYELINATING DISEASE: VIRAL AND IMMUNE FUNCTION
$1,218,244Stephen A. Stohlman · Cleveland Clinic Lerner Com-Cwru · P01 · FY2007 · NS
DEMYELINATION DISEASE--VIRAL AND IMMUNE FUNCTION
$1,218,037University Of Southern California · P01 · FY2002 · NS
PROJECT 2:Structural studies of SOSIP trimers
$1,217,315Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
A Multi-site Multi-Setting RCT of Integrated HIV Prevention and HCV Care for PWID
$1,217,167Lisa R Metsch · Columbia University Health Sciences · R01 · FY2022 · DA
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$1,215,815Pablo Tebas · University Of Pennsylvania · UM1 · FY2017 · AI
Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis
$1,215,278Ramon Bataller · Univ Of North Carolina Chapel Hill · U01 · FY2013 · AA
Molecular Genetics Of Heritable Human Disorders
$1,215,136Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
USC Research Center for Liver Disease
$1,215,000Neil Kaplowitz · University Of Southern California · P30 · FY2014 · DK
USC Research Center for Liver Disease
$1,215,000Neil Kaplowitz · University Of Southern California · P30 · FY2012 · DK
DRUG INTERACTIONS
$1,214,958University Of Washington · P01 · FY2001 · GM
Liver Pathobiology and Gene Therapy Research Core Center
$1,214,925David A Shafritz · Albert Einstein College Of Medicine · P30 · FY2006 · DK
Liver-Targeted Prodrugs for the Treatment of Hepatitis C
$1,214,585Metabasis Therapeutics, Inc. · R44 · FY2003 · AI
Women's Interagency HIV Study (WIHS) IV
$1,214,280Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny) · U01 · FY2010 · AI
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$1,213,990Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
$1,213,726Shruti H Mehta · Johns Hopkins University · R01 · FY2017 · DA
Prevention of Substance Use in At-risk Students: A Family-centered Web Program
$1,213,204Elizabeth A Stormshak · University Of Oregon · R01 · FY2021 · DA
Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma
$1,212,701Kenneth H Buetow · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Addressing alcohol misuse in HIV prevention and care: The Brown University Alcohol Research Center on HIV (ARCH)
$1,212,682Christopher W. Kahler · Brown University · P01 · FY2024 · AA
Hispanic Health Disparities Research Center
$1,212,299Elias Provencio-Vasquez · University Of Texas El Paso · P20 · FY2012 · MD
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,211,368Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2021 · AI
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERS
$1,211,172Johns Hopkins University · R37 · FY2001 · DA
USC Research Center for Liver Disease
$1,210,578Neil Kaplowitz · University Of Southern California · P30 · FY2010 · DK
Validation of a human in vitro system of hepatic steatohepatitis
$1,210,475Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2016 · DK
Colorado Emerging Infections Program
$1,210,463Ken A. Gershman · Colorado State Dept/Pub Hlth & Environmt · U01 · FY2011 · CI
HIV vaccine swarms for PWID
$1,210,300Pablo Penaloza · Beth Israel Deaconess Medical Center · DP1 · FY2025 · DA